Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,709 GBX | +0.20% | +2.08% | +17.82% |
Mar. 28 | GSK : Sell rating from JP Morgan | ZD |
Mar. 28 | U.S. FDA approves Akebia's anemia drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.82% | 88.25B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock GSK plc - London S.E.
- News GSK plc
- GlaxoSmithKline : Shingles Vaccine Receives Recommendation in US for Immunocompromised Adults